U.S. Stocks on the Move | Moderna (MRNA.US) Rises 5%, Share Price Nears All-Time High

Zhitong Finance APP has learned that on Monday, Moderna (MRNA.US) rose more than 8% at one point in early trading. As of press time, the gain had narrowed to 5%, at $229.69, with the stock price approaching its historical high. On the news front, on October 17, Moderna and Merck presented the Phase III study results of their personalized cancer therapy intismeran autogene combined with Keytruda in melanoma, and reports noted that the candidate therapy achieved positive progress.